Ai Mediq was happy to be one of the seventeen Luxembourg companies presented during IHI Kick-off and brokerage event that took place on June 14, 2022 in Brussels, Belgium.
The results of the application of ReOxy therapy in patients with osteoarthritis and post-covid syndrome has been demonstrated during the presentation at Eular22
Arab Health 2022 is now over.
We had fantastic time spent with our colleagues and partners. We are looking forward to further work of expansion of our presence in the region and the world as a whole.
Ai Mediq announces it’s participation in largest professional event in MENA region – Arab Health 2022.
The first day of the largest professional medical exhibition Medica has started after a one year brake.
Ai Mediq is looking forward to seeing all our existing partners and new potential collaborators at joint booth of Ministry of Economy of Grand Duchy of Luxembourg in Hall 3, stand A74.
The team led by Prof. Schega from the Department of Health and Physical Activity at the Otto von Guericke University in Magdeburg (Faculty of Human Sciences, Institute III, Sports Sciences) is currently conducting the clinical study “Effects of intermittent hypoxia-hyperoxia on cognitive function, mobility and wellbeing in patients with dementia”
Dzień dobry, panie i panowie! Ai Mediq here, just to let you know that we are expanding our presence in Eastern Europe. We have rolled-out the Polish translation of our web-site and are happy to develop the Polish market further in close cooperation with our partner Kinesis. Enjoy and let us know what you think!
Ai Mediq is publishing a translation of publication by Prof. Oleg S. Glazachev for RBC.RU regarding the implications of COVID-19 and therapeutic potential of application of ReOxy device to rehabilitate the patients.
Ai Mediq S.A. is pleased to announce the new stage of scientific cooperation with the Universitätsklinikum Hamburg-Eppendorf (UKE). Together with Dr. Sina Cathérine Rosenkranz we will be looking into potential perspectives of Interval Hypoxic Therapy in the treatment of multiple sclerosis.